tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Adient price target raised to $15 from $13 at UBS

UBS raised the firm’s price target on Adient (ADNT) to $15 from $13 and keeps a Neutral rating on the shares. Tariff mitigation led to a reiterated outlook for fiscal 2025, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1